Ulf Bömer
Impact in
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders
- Molecular Biology top 10%
- Mitochondrial Function and Pathology
- ATP Synthase and ATPases Research
- RNA and protein synthesis mechanisms
- RNA modifications and cancer
- Photosynthetic Processes and Mechanisms
- Heat shock proteins research
- DNA Repair Mechanisms
Papers in ⓘ
-
- Mitochondrial Function and Pathology 10
- RNA and protein synthesis mechanisms 6
- ATP Synthase and ATPases Research 4
- RNA Research and Splicing 3
- Melanoma and MAPK Pathways 2
- RNA modifications and cancer 2
- Kruppel-like factors research 1
- Oncology 4
- Co-authors
- Nikolaus Pfanner (9 shared papers)Angelika Hönlinger (4 shared papers)Klaus Dietmeier (4 shared papers)Oliver von Ahsen (1 shared paper)Christoph Eckerskorn (2 shared papers)Michael Kübrich (2 shared papers)Joachim Rassow (4 shared papers)P. Dekker (2 shared papers)
- Journals
- The EMBO Journal (4 papers)Journal of Medicinal Chemistry (2 papers)Cancer Research (2 papers)Molecular Cancer Therapeutics (1 paper)SLAS DISCOVERY (1 paper)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Ulf Bömer
23 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 77
- Clinical Biochemistry 151
- Molecular Biology 1.3k
- Oncology 187
- Aging 11
- Cell Biology 85
Countries citing papers authored by Ulf Bömer
This map shows the geographic impact of Ulf Bömer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Bömer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Bömer more than expected).
Fields of papers citing papers by Ulf Bömer
This network shows the impact of papers produced by Ulf Bömer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Bömer. The network helps show where Ulf Bömer may publish in the future.
Co-authors
The 25 scholars most cited alongside Ulf Bömer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 227 | |
| 2 | 2019 | 145 | |
| 3 | 1996 | 144 | |
| 4 | 2005 | 112 | |
| 5 | 2000 | 111 | |
| 6 | 1997 | 108 | |
| 7 | 2021 | 53 | |
| 8 | 1998 | 52 | |
| 9 | 1996 | 51 | |
| 10 | 1997 | 51 | |
| 11 | 2016 | 51 | |
| 12 | 2017 | 48 | |
| 13 | 1996 | 46 | |
| 14 | 1995 | 44 | |
| 15 | 2018 | 40 | |
| 16 | 1997 | 35 | |
| 17 | 2019 | 32 | |
| 18 | 2021 | 29 | |
| 19 | 1997 | 14 | |
| 20 | 2006 | 3 |
About Ulf Bömer
Ulf Bömer is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Organic Chemistry, having authored 23 papers that have together received 1.4k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (10 papers), RNA and protein synthesis mechanisms (6 papers), ATP Synthase and ATPases Research (4 papers), RNA Research and Splicing (3 papers), Melanoma and MAPK Pathways (2 papers), Cancer Mechanisms and Therapy (2 papers), RNA modifications and cancer (2 papers) and Kruppel-like factors research (1 paper). The work is most often cited by research in Clinical Biochemistry (151 citations), Molecular Biology (1.3k citations), Oncology (187 citations), Aging (11 citations) and Cell Biology (85 citations). Ulf Bömer has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Nikolaus Pfanner, Angelika Hönlinger, Klaus Dietmeier, Oliver von Ahsen, Christoph Eckerskorn, Michael Kübrich, Joachim Rassow, P. Dekker, Bernard Guiard and Fritz Lottspeich. Their work appears in journals such as The EMBO Journal, Journal of Medicinal Chemistry, Cancer Research, Molecular Cancer Therapeutics and SLAS DISCOVERY.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.